Investigational Site Number : 1000013

Dupnitsa 2600

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma — Completed